TVT Versus TOT in Urinary Stress Incontinence With No Intrinsic Sphincter Deficiency
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01903590|
Recruitment Status : Completed
First Posted : July 19, 2013
Last Update Posted : July 1, 2014
|Condition or disease||Intervention/treatment||Phase|
|Female Urinary Stress Incontinence||Procedure: TVT surgery TOT surgery||Not Applicable|
Patients with isolated stress incontinence attending to Dr Zekai Tahir Burak Woman Health Teaching and Research Hospital Urogynecology Department will be prospectively randomized,by a computer generated randomisation code,to the TVT or TOT. The patients will be aware of the type of the surgical procedure before the operation.
Preoperative evaluation includes clinical history,urinanalysis,pelvic examination QoL assessment and urodynamic study. QoL included Urogenital Distress Inventory Short Form (UDI-6) and the Incontinence Impact Questionnaire Short Form( IIQ-7).Urodynamic study includes cystometry,urethral profilometry and Valsalva leak point pressure (VLPP).In all patients,pelvic floor defect will be evaluated according to the POP quantification (POPQ) staging.To diagnose the occult stress incontinence in patients with pelvic prolapse, a cough test after reducing the prolapse will be performed.Patients will be followed up at 6 and 12 months postoperatively.Objective cure is defined as a negative cough stress test .Negative cough stress test ,but occasional urine leakage during stress will be considered ''improved''.
Postoperative subjective outcomes will be categorized as follows:cured (UDI-6 and IIQ-7 postoperative<10), improved (UDI-6 and IIQ-7 if postoperative>preoperative) and worsened (UDI-6 and IIQ-7 if postoperative<preoperative).
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||PROSPECTIVE RANDOMIZED STUDY COMPARING TVT AND TOT IN FEMALE STRESS URINARY INCONTINENCE WITH NO INTRINSIC SPHINCTER DEFICIENCY|
|Study Start Date :||June 2013|
|Actual Primary Completion Date :||June 2014|
|Actual Study Completion Date :||June 2014|
Active Comparator: Transvaginal Tape Surgery
Randomized 50 patients undergoing TVT
Procedure: TVT surgery TOT surgery
Experimental: Transobturator tape surgery
Randomized 50 patients undergoing TOT
Procedure: TVT surgery TOT surgery
- Comparison of the efficiency of TVT and TOT in stress incontinence with no intrinsic deficiency [ Time Frame: One year ]Postoperative UDI-6 and IIQ-7 <10 and negative cough test will be defined as ''cured''
- Objective effectiveness by cough test at 6 and 12 th months postoperatively [ Time Frame: One year ]A patient with a bladder filled 300 cc saline will cough and if no leakage of urine,the patient will be described as ''cured''.
- Subjective effectiveness by UDI-6 and IIQ-7 at 6-12 th months postoperatively [ Time Frame: One year ]Postoperative subjective outcomes will be categorized as follows:cured (UDI-6 and IIQ-7 postoperative<10), improved (UDI-6 and IIQ-7 if postoperative>preoperative) and worsened (UDI-6 and IIQ-7 if postoperative<preoperative).
- Short term and long term surgical complications [ Time Frame: One year ]Bleeding,bladder and bowel perforation,mesh erosion etc..
- The prevalence of voiding dysfunction at 1 and 12 th months postoperatively [ Time Frame: One year ]Postoperative residual volume after first voiding >100 cc ,difficulty in voiding will be described as ''voiding dysfunction''.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01903590
|Dr Zekai Tahir Burak Woman Health Teaching and Research Hospital|
|Ankara, Cankaya, Turkey, 06590|
|Principal Investigator:||Sabri Cavkaytar, MD||Zekai Tahir Burak Women's Health Research and Education Hospital|